Inspire Investing’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Sell |
43,209
-2,692
| -6% | -$24.1K | 0.04% | 672 |
|
|
2025
Q1 | $344K | Sell |
45,901
-7,578
| -14% | -$56.8K | 0.04% | 491 |
|
|
2024
Q4 | $402K | Sell |
53,479
-104,529
| -66% | -$786K | 0.05% | 450 |
|
|
2024
Q3 | $1.2M | Buy |
158,008
+100,458
| +175% | +$763K | 0.12% | 178 |
|
|
2024
Q2 | $356K | Sell |
57,550
-11,916
| -17% | -$73.6K | 0.04% | 396 |
|
|
2024
Q1 | $353K | Buy |
69,466
+6,141
| +10% | +$31.2K | 0.04% | 782 |
|
|
2023
Q4 | $379K | Buy |
63,325
+20,255
| +47% | +$121K | 0.04% | 772 |
|
|
2023
Q3 | $305K | Sell |
43,070
-1,513
| -3% | -$10.7K | 0.04% | 747 |
|
|
2023
Q2 | $314K | Buy |
44,583
+12,234
| +38% | +$86.1K | 0.04% | 590 |
|
|
2023
Q1 | $270K | Buy |
32,349
+11,559
| +56% | +$96.4K | 0.03% | 768 |
|
|
2022
Q4 | $239K | Buy |
20,790
+4,402
| +27% | +$50.5K | 0.03% | 367 |
|
|
2022
Q3 | $206K | Buy |
+16,388
| New | +$206K | 0.03% | 593 |
|